Beta Bionics, Inc. - 8-K Filing
Beta Bionics announced an updated commercialization timeline for its patch pump, Mint, expecting to fully launch it by the end of Q2 2027, pending FDA clearance. The update follows initial feedback from the FDA on its ACE insulin pump 510(k) application and progress in scaling manufacturing processes. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $BBNX